1h Free Analyst Time
The Gastrointestinal Bleeding Treatment Devices Market grew from USD 534.43 million in 2023 to USD 559.43 million in 2024. It is expected to continue growing at a CAGR of 5.26%, reaching USD 765.43 million by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Gastrointestinal bleeding treatment devices play a crucial role in managing internal bleeding within the gastrointestinal tract, covering a range of devices like endoscopic hemostasis devices, closure devices, and radio frequency ablation devices. These medical devices are necessary in providing efficient, minimally invasive solutions tailored to treat various types of bleeding ulcers and lesions, encompassing applications in both upper and lower gastrointestinal tracts. Predominantly used in hospitals, ambulatory surgical centers, and specialized clinics, these devices offer significant advancements in patient care by reducing the need for more invasive surgical interventions. The market is driven by key factors such as the increasing prevalence of gastrointestinal disorders, a growing geriatric population, and technological innovations catering to precise and efficient treatment methods. An expanding healthcare infrastructure across emerging economies also propels market growth, boosting accessibility and adoption.
Nevertheless, challenges such as high costs associated with advanced devices, stringent regulatory barriers, and limited awareness in underdeveloped regions can impede market expansion. For businesses, an emphasis on innovation is critical, particularly in areas like improving device efficacy, enhancing user-friendliness, and integrating AI and machine learning for predictive diagnostics and outcomes. Furthermore, the development of cost-effective and portable devices tailored for under-resourced regions presents lucrative opportunities. Collaborations with healthcare providers for real-time feedback and clinical trials can foster further innovation and user-centric product development. As the market evolves, companies should focus on comprehensive market research to understand regional dynamics, investing in R&D to stay ahead in technological advancements, and fostering partnerships for wider distribution networks. Navigating regulatory landscapes with strategic guidance is imperative to streamline device approvals and market entry. Thus, by aligning innovative research with market needs and leveraging technological advancements, businesses can capitalize on emerging opportunities in the gastrointestinal bleeding treatment devices market.
Understanding Market Dynamics in the Gastrointestinal Bleeding Treatment Devices Market
The Gastrointestinal Bleeding Treatment Devices Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.- Market Drivers
- Government initiatives and favorable reimbursement policies for gastrointestinal bleeding treatments
- Rising healthcare expenditure and improving healthcare infrastructure in emerging economies
- Increasing adoption of minimally invasive procedures for treating gastrointestinal bleeding
- Collaborations and partnerships between key players driving product development and market growth
- Market Restraints
- High costs associated with the development and deployment of advanced gastrointestinal bleeding treatment technologies
- Limited awareness among general healthcare providers about advancements in gastrointestinal bleeding treatments
- Market Opportunities
- Integration of advanced diagnostic imaging technologies in gastrointestinal bleeding treatment devices to improve early detection and precision
- Collaborations between gastrointestinal bleeding treatment device manufacturers and healthcare providers to enhance patient care and treatment outcomes
- Market Challenges
- Complex patient needs necessitate the development of highly specialized gastrointestinal bleeding treatment solutions
Exploring Porter’s Five Forces for the Gastrointestinal Bleeding Treatment Devices Market
Porter’s Five Forces framework further strengthens the insights of the Gastrointestinal Bleeding Treatment Devices Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.Applying PESTLE Analysis to the Gastrointestinal Bleeding Treatment Devices Market
External macro-environmental factors deeply influence the performance of the Gastrointestinal Bleeding Treatment Devices Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.Analyzing Market Share in the Gastrointestinal Bleeding Treatment Devices Market
The Gastrointestinal Bleeding Treatment Devices Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.Evaluating Vendor Success with the FPNV Positioning Matrix in the Gastrointestinal Bleeding Treatment Devices Market
The Gastrointestinal Bleeding Treatment Devices Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.Strategic Recommendations for Success in the Gastrointestinal Bleeding Treatment Devices Market
The Gastrointestinal Bleeding Treatment Devices Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.Key Company Profiles
The report delves into recent significant developments in the Gastrointestinal Bleeding Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include 3M, Abbott Laboratories, Boston Scientific, CONMED Corporation, Cook Medical, Erbe Elektromedizin GmbH, Fujifilm Holdings Corporation, Hoya Corporation, Intuitive Surgical, Johnson & Johnson, Karl Storz SE & Co. KG, Medtronic, Merit Medical Systems, Olympus, Pentax Medical, Smith & Nephew, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, and Zimmer Biomet.Market Segmentation & Coverage
This research report categorizes the Gastrointestinal Bleeding Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product Type
- Endoscopic Hemostatic Devices
- Hemostatic Clips
- Injection Devices
- Spray Devices
- Thermal Devices
- Radiological Interventions
- Embolization Agents
- Sclerosants
- Endoscopic Hemostatic Devices
- Treatment Type
- Drug Therapy
- Octreotide
- Terlipressin
- Endoscopic Treatment
- Injection Therapy
- Mechanical Therapy
- Thermal Coagulation
- Surgical Treatment
- Laparoscopic Surgery
- Open Surgery
- Drug Therapy
- End User
- Ambulatory Surgical Centers
- Clinics
- Hospitals
- Private Hospitals
- Public Hospitals
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report provides a detailed overview of the market, exploring several key areas:
- Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
- Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
- Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
- Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
- Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current size of the market, and how is it expected to grow?
- Which products, segments, and regions present the most attractive investment opportunities?
- What are the prevailing technology trends and regulatory factors influencing the market?
- How do top vendors rank regarding market share and competitive positioning?
- What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Government initiatives and favorable reimbursement policies for gastrointestinal bleeding treatments
5.1.1.2. Rising healthcare expenditure and improving healthcare infrastructure in emerging economies
5.1.1.3. Increasing adoption of minimally invasive procedures for treating gastrointestinal bleeding
5.1.1.4. Collaborations and partnerships between key players driving product development and market growth
5.1.2. Restraints
5.1.2.1. High costs associated with the development and deployment of advanced gastrointestinal bleeding treatment technologies
5.1.2.2. Limited awareness among general healthcare providers about advancements in gastrointestinal bleeding treatments
5.1.3. Opportunities
5.1.3.1. Integration of advanced diagnostic imaging technologies in gastrointestinal bleeding treatment devices to improve early detection and precision
5.1.3.2. Collaborations between gastrointestinal bleeding treatment device manufacturers and healthcare providers to enhance patient care and treatment outcomes
5.1.4. Challenges
5.1.4.1. Complex patient needs necessitate the development of highly specialized gastrointestinal bleeding treatment solutions
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Gastrointestinal Bleeding Treatment Devices Market, by Product Type
6.1. Introduction
6.2. Endoscopic Hemostatic Devices
6.2.1. Hemostatic Clips
6.2.2. Injection Devices
6.2.3. Spray Devices
6.2.4. Thermal Devices
6.3. Radiological Interventions
6.3.1. Embolization Agents
6.3.2. Sclerosants
7. Gastrointestinal Bleeding Treatment Devices Market, by Treatment Type
7.1. Introduction
7.2. Drug Therapy
7.2.1. Octreotide
7.2.2. Terlipressin
7.3. Endoscopic Treatment
7.3.1. Injection Therapy
7.3.2. Mechanical Therapy
7.3.3. Thermal Coagulation
7.4. Surgical Treatment
7.4.1. Laparoscopic Surgery
7.4.2. Open Surgery
8. Gastrointestinal Bleeding Treatment Devices Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Clinics
8.4. Hospitals
8.4.1. Private Hospitals
8.4.2. Public Hospitals
9. Americas Gastrointestinal Bleeding Treatment Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Gastrointestinal Bleeding Treatment Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Gastrointestinal Bleeding Treatment Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET DYNAMICS
TABLE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EMBOLIZATION AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SCLEROSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OCTREOTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TERLIPRESSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MECHANICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 67. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 69. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 70. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 72. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 74. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 81. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 83. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 114. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 116. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 117. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 118. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 119. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 120. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 121. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 123. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 125. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 126. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 128. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 129. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 130. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 132. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 134. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 141. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 143. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 144. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 145. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 146. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 147. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 148. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 150. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 152. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 159. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 161. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 165. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 168. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 170. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 172. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 177. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 179. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 180. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 181. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 183. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 186. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 188. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 189. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 190. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 195. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 197. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 198. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 199. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 200. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 201. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 202. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 204. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 206. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 207. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 208. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 210. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 223. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 225. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 226. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 227. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 228. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 229. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 230. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 232. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 234. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 235. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 236. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 237. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 238. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 239. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 243. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 244. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 245. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 246. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 247. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 248. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 250. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 252. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 253. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 254. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 255. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 256. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 257. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 259. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
TABLE 261. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 262. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 263. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 264. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 265. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 266. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUC
Companies Mentioned
The leading players in the Gastrointestinal Bleeding Treatment Devices Market, which are profiled in this report, include:- 3M
- Abbott Laboratories
- Boston Scientific
- CONMED Corporation
- Cook Medical
- Erbe Elektromedizin GmbH
- Fujifilm Holdings Corporation
- Hoya Corporation
- Intuitive Surgical
- Johnson & Johnson
- Karl Storz SE & Co. KG
- Medtronic
- Merit Medical Systems
- Olympus
- Pentax Medical
- Smith & Nephew
- Stryker Corporation
- Teleflex Incorporated
- Terumo Corporation
- Zimmer Biomet
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 187 |
Published | October 2024 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 559.43 Million |
Forecasted Market Value ( USD | $ 765.43 Million |
Compound Annual Growth Rate | 5.2% |
Regions Covered | Global |
No. of Companies Mentioned | 20 |